Clinical trial
A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
NCT00516165 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- November 30, 2011
- Enrollment
- 28 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma